Pathogenomix Developing Infectious Disease Testing Platform

The firm obtained FDA breakthrough device designation for an NGS approach to identify up to 400 bacterial pathogens used to diagnose sepsis and other bacterial infections.

Related Keywords

California , United States , Redwood City , San Francisco , Tim Sweeney , Diasorin Luminex , Chris Risley , University Of California , Drug Administration , Us Centers For Disease , Santa Cruz , Genmark Diagnostics , Biofire Diagnostics , Accelerate Diagnostics , Mayo Clinic Laboratories , Mayo Clinic , Clinical Infectious Diseases , Disease Control , Clinical Microbiology , Roche Diagnostic , San Diego Based , San Francisco Based , Core Reference Laboratories ,